# Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia

> **NCT01292577** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 33 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **BEHAVIORAL:** CET/PT
- **BEHAVIORAL:** Treatment as Usual

## Key facts

- **NCT ID:** NCT01292577
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2014-05
- **Final completion:** 2014-09
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01292577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01292577, "Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01292577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*